DL-3,4-Dihydroxyphenyl glycol

N-[[2-[[[4-(氨基亚胺甲基)苯基]氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]-N-2-吡啶基-BETA-丙氨酸乙酯;2-氯-4-乙羟喹啉;N-[[2-[[[(4-(氨基亚胺甲基)苯基]胺基]甲基]-1甲基-1H-5-苯并咪;N-[[2-[[[(4-(氨基亚胺甲基)苯基]胺基]甲基]-1甲基-1H-5-苯并咪唑]羰基]N-2-吡啶基-b-丙氨酸乙酯;甲磺酸达比加群酯;N-[[2-[[[(4-(氨基亚胺甲基)苯基]胺基]甲基]-1甲基-1H-5-苯并咪唑]羰基]N-2-吡啶基-丙氨酸乙酯;Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate;达比加群乙酸乙酯

DL-3,4-Dihydroxyphenyl glycol

Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate;3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N -(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)prop anoate hydrochloride;Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester;Dabigatran (ethyl ester);DABIGATRAN ETHYL ACOH SALT;Dabigatran Ethyl Ester;Ethyl3-(2-((4-carbamimidoylphenylamino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate;N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-;N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester;3-({2-[(4-CARBAMIMIDOYL-PHENYLAMINO)-METHYL]-3-METHYL-3H-BENZOIMIDAZOLE-5-CARBONYL}-PYRIDIN-2-YL-AMINO)-PROPIONIC ACID ETHYL ESTER;AC1L9K40;C24;CHEBI:41302;CHEMBL1231568;CTK8B6269;SureCN3027080

28822-73-3

C₂₇H₂₉N₇O₃

499.56

Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cardiovascular System|Vasculature|Vasoconstriction||Research Area|Cardiovascular System|Vasculature|Vasodilation||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Neuroscience||Research Area|Oxidative Stress & Reactive Species|Antioxidant Activity||Research Area|Oxidative Stress & Reactive Species|Reactive Nitrogen|iNOS||Research Area|Oxidative Stress & Reactive Species|Reactive Oxygen|Non-Enzymatic